久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis drugs
    July 23, 2021
    FDA has granted approval to Octapharma USA for Octagam? 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin to be indicated for the treatment of adult dermatomyositis, a rare immune-mediated inflammatory disease.
PharmaSources Customer Service